Sitting less for Black adults with chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a program to help Black adults with chronic kidney disease sit less and move more throughout the day. You might join if you spend 6 or more hours sitting each day and can walk and stand without help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You identify as Black or African American.
- You are between 35 and 80 years old.
- You have chronic kidney disease at stage 1, 2, 3, or 4.
- You sit for 6 or more hours each day.
- You can walk at least one block and stand up from a chair without help.
- You have a telephone and can speak and understand English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether watching educational videos about exercise and staying active can improve physical fitness for people with early to moderate chronic kidney disease. You can take part from home using a smartphone, tablet, or computer.
This study tests whether a personalized exercise program can help adults over 55 with chronic kidney disease regain strength and mobility after a hospital stay.
This study is testing a computer-based education program for African American patients with chronic kidney disease. It aims to help you better understand your condition and treatment options.
This study tests whether a special education and referral program helps Black patients with advanced kidney disease learn about their treatment options before they need dialysis or a transplant. If you join, you will get extra support while you're in the hospital.
This study tests a simple program that combines muscle relaxation exercises and walking to help reduce fatigue in people with end-stage kidney disease who are on dialysis. You'll receive text messages to guide you and track your progress.
This Phase 2 study tests a program to help people with chronic kidney disease (CKD) sit less and move more, plus a medication (semaglutide) for those who qualify. It may help improve health and day-to-day activity while monitoring safety closely.
Hear when a new Chronic Kidney Disease(CKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.